Medium materiality6/10
Ultragenyx downgraded to Neutral from Outperform at Baird
Why it may matterVerify against the original reporting
sell
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
sell
What happened, with direct paths to the underlying reporting
Ultragenyx downgraded to Neutral with a target of $16; current price is $26.53.
Target: $16
Posted price: $26.53
Analyst firm: Robert W. Baird
Analyst: Jack Allen
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.